Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Healthcare Electronic Data Interchange (EDI) market: $1.7 Bn against $73 Mn in 2023, about 23 times as large.
India grows faster: 12.4% a year, against 7.4%. The gap still grows from $1.6 Bn to $3.2 Bn by 2033.
Clinical research: 59 active trials in the US, 2 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $1.7 Bn | $73 Mn |
| Market size, 2033 projected | $3.4 Bn | $234 Mn |
| Growth a year (CAGR) | 7.4% | 12.4% |
| Money added, 2023–2033 | $1.8 Bn | $161 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $4.92 | $0.05 |
| Active clinical trials | 59 | 2 |
| Full report | US report | India report |
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Healthcare Electronic Data Interchange (EDI) market: $1.7 Bn against $73 Mn in 2023, about 23 times as large.
India grows faster: 12.4% a year, against 7.4%. The gap still grows from $1.6 Bn to $3.2 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.